The importance of risk factor reduction in erectile dysfunction

Current Sexual Health Reports

Volumn 4, Issue 3, 2007, Pages 114-117

  Jackson, Graham ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR;

ALCOHOL CONSUMPTION; BODY MASS; CARDIOVASCULAR RISK; DRUG EFFICACY; ENDOTHELIAL DYSFUNCTION; ERECTILE DYSFUNCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMOBILIZATION; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; OBESITY; PHYSICAL ACTIVITY; REVIEW; RISK FACTOR; SMOKING; WEIGHT REDUCTION;

EID: 34548761591     PISSN: 15483584     EISSN: 15483592     Source Type: Journal    
DOI: 10.1007/s11930-007-0012-3     Document Type: Review

References (27)

1. Solomon H, Man JW, Jackson G: Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 2003, 89:251-253.
2. Montorsi P, Ravagnani PM, Galli S, et al.: Association between erectile dysfunction and coronary artery disease: matching the right target with the right test in the right patient. Eur Urol 2006, 50:721-731. This article shows the importance of evaluating the ED patient for CAD and how to do it.
3. Jackson G: Erectile dysfunction: a marker of silent coronary artery disease. Eur Heart J 2006, 27:2613-2614.
4. Vlachopoulos C, Aznaouridis K, Ioakeimidis N, et al.: Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease. Eur Heart J 2006, 27:2640-2648. This article shows ED is linked to increased inflammatory markers possibly acting as a predictor for CAD.
5. Jackson G, Rosen RC, Kloner RA, Kostis JB: The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine. J Sex Med 2006, 3:28-36. This article presents new comprehensive guidelines.
6. Bacon CG, Mittleman MA, Kawachi I, et al.: A prospective study of risk factors for erectile dysfunction. J Urol 2006, 176:217-221.
7. Blanker MH, Bohnen AM, Groeneveld FP, et al.: Correlates for erectile and ejaculatory dysfunction in older Dutch men: a community-based study. J Am Geriatr Soc 2001, 49:436-442.
8. Holden CA, McLachlan RI, Pitts M, et al.: Men in Australia Telephone Survey (MATeS) I: a national survey of the reproductive health and concerns of middle aged and older Australian men. Lancet 2005, 366:218-224.
9. Kapelman PG: Obesity as a medical problem. Nature 2000, 404:635-643.
10. Yudkin JS, Stehouwer CD, Emeis JJ, et al.: C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999, 19:972-978.
11. Esposito K, Giugliano F, Di Palo C, et al.: Effect of lifestyle changes on erectile dysfunction in men: a randomised controlled trial. JAMA 2004, 291:2978-2984. This article shows the importance of intensive lifestyle advice.
12. Laurmann EO, Nicolosi A, Glasser DB, et al.: Sexual problems among women and men aged 40-80 years: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviour. Int J Impot Res 2005, 17:39-57.
13. Johannes CB, Araujo AB, Fieldman HA, et al.: Incidence of erectile dysfunction in men aged 40 to 69 years old: longitudinal results from the Massachusetts Male Aging Study. J Urol 2000, 163:460-463.
14. Juenemann KP, Lue TF, Luo JA, et al.: The effect of cigarette smoking on penile erection. J Urol 1987, 138:438-441.
15. Glina S, Reichet AC, Leao PP, et al.: Impact of cigarette smoking onpapaverine-inducederection. J Urol 1988, 140:523-524.
16. Jackson G: The metabolic syndrome and erectile dysfunction: multiple vascular risk factors and hypogonadism. Eur Urol 2006, 50:426-427.
17. Esposito K, Giugliano F, Margedi E et al.: High proportions of erectile dysfunction in men with the metabolic syndrome. Diabetes Care 2005, 28:1201-1203. This article records the ED-metabolic syndrome link.
18. Kupelian V, Shabsigh R, Araujo AA, et al.: Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts Male Aging Study. J Urol 2006, 176:222-226.
19. Corona G, Mannucci E, Schulmann C, et al.: Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. Eur Urol 2006, 50:595-602. This article correlates low testosterone with increasing severity of metabolic syndrome.
20. Makhsida N, Shah J, Yan G, et al.: Hypogonadism and metabolic syndrome: implications for testosterone therapy. J Urol 2005, 174:827-834.
21. ̧Esposito K, Ciobola M, Giugliano F, et al.: Mediterranean diet improves erectile function in subjects with the metabolic syndrome. Int J Impot Res 2006, 18:405-410. This article makes an important lifestyle observation.
22. Bruckert E, Giral P, Heshmati HM, Turpin G: Men treated with hypolipidaemic drugs complain more frequently of erectile dysfunction. J Clin Pharm Ther 1996, 21:89-94.
23. Solomon H, Samarasingh YP, Feher MD, et al.: Erectile dysfunction and statin treatment in high cardiovascular risk patients. Int J Clin Pract 2006, 60:141-148.
24. Hermann HC, Levine LA, Macalusa J, et al.: Can atorvastatin improve the response to sildenafil in men with erectile dysfunction not initially responsive to sildenafil? Hypothesis and pilot trial results. J Sex Med 2006, 3:303-308.
25. Solomon H, Wierzbicki AS, Lumb PJ, et al.: Cardiovascular risk factors determine erectile and arterial function response to sildenafil. Am J Hypertens 2006, 19:915-919.
26. Fogari R, Zoppi A, Polett L, et al.: Sexual activity in hypertensive men treated with valsartan or Carvedilol: a crossover study. Am J Hypertens 2001, 14:27-31.
27. Jackson G: Erectile dysfunction and hypertension. Int J Clin Pract 2002, 56:491-492.